SecBot SecBot
ANALYST-UPGRADE ·Filed Aug 19, 2026

ASND

Ascendis Pharma A/S
BULLISH
Impact 4/10
Horizonmonths Processed2mo ago SECanalyst-ASND-bmocapit-20260819
BMO Capital initiates coverage on ASND at Outperform
Actionable Insight ▲ Bullish

BMO's initiation adds to a bullish consensus backed by insider buying, but the high short interest and downward EPS revisions create a mixed setup. Traders should watch for a catalyst to break the short squeeze potential, but the falling estimates warrant caution on near-term entry.

DirectionBullish
Confidencemedium
Horizonmonths

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$259.62
T+0 close · Aug 19, 2026 · via day close
Latest settled
+2.87%
T+60 · $267.07
Vs SPY
+4.42%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 19 $259.62entry
  2. T+1 · 3mo ago −1.85%α −1.01% · $254.81
  3. T+5 · 3mo ago −3.61%α −3.22% · $250.25
  4. T+20 · 2mo ago −7.93%α −5.98% · $239.04
  5. T+60 · 4d ago +2.87%α +4.42% · $267.07
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BMO Capital initiated coverage on Ascendis Pharma A/S (ASND) at Outperform with a $319 price target, representing 28% upside from the current $248.85. The firm's 53% accuracy on 1,841 calls and 2.3% average return places it near the middle of the 14 firms covering ASND. Consensus is heavily bullish: 25 of 26 analysts rate it Buy, one Hold, zero Sell. The mean price target is $310.30, median $306.45, high $361.21, low $261.39, BMO's $319 sits above the median and mean, indicating above-consensus conviction. Momentum is positive with one upgrade and zero downgrades in the past 30 days, though EPS estimates for the current quarter and year have been revised down over the past week and month. Insider buying is strong: CEO Jean Jacques Bienaime made two purchases totaling $492,654 on August 14, and other insiders bought in May and June. Short interest is elevated at 68.8% of float, creating potential for a squeeze if positive catalysts materialize. Bottom line: BMO's initiation aligns with a bullish consensus and is reinforced by insider buying, but the high short interest and downward EPS revisions warrant caution.

Impact Score

Base Score
2/7
LLM Adjustment
+1
Final Score
4/10

Consensus & Targets

Buy / Strong Buy
25 (96%)
Hold
1
Sell / Strong Sell
0
Total Analysts
18
Mean PT
$310.30
Median PT
$306.45
High PT
$361.21
Low PT
$261.39
Current Price
$248.85
Implied Upside
+24.7%

Consensus is overwhelmingly bullish: 12 Strong Buy, 13 Buy, 1 Hold, 0 Sell, 0 Strong Sell across 26 analysts. That's 96% Buy-equivalent ratings, indicating near-unanimous positive sentiment. BMO's Outperform aligns with this direction.

Current price: $248.85. Mean target: $310.30 (25% upside). Median: $306.45. High: $361.21 (45% upside). Low: $261.39 (5% upside). BMO's $319 is above the mean and median, reflecting above-consensus optimism. The implied upside to BMO's PT is 28%.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-08-19BMO CapitalinitiateOutperform$319.00
2026-08-14TD CowenmaintainBuy$341.00
2026-08-14RBC CapitalmaintainOutperform$290.00
2026-08-14BarclaysmaintainOverweight$329.00
2026-07-23Morgan StanleymaintainOverweight$275.00
2026-07-07RBC CapitalmaintainOutperform$280.00
2026-05-19CitigroupinitiateBuy$355.00
2026-05-15Evercore ISI GroupmaintainOutperform$329.00
2026-05-11BarclaysmaintainOverweight$345.00
2026-05-08Wells FargomaintainOverweight$326.00

30-day analyst activity: 1 upgrade (BMO's initiation), 0 downgrades. EPS revisions are negative: current quarter EPS estimate fell from $1.32 to $0.95 over 30 days, and current year estimate dropped from $11.82 to $11.34. Next year's estimate also declined from $9.21 to $8.16. This divergence, bullish ratings but falling estimates, is a cautionary signal.

Firm Track Record: BMO Capital

BMO Capital accuracy: 53% on 1841 calls | avg return: 2.3%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 14 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
RBC Capital100%3/35.2%top tier
Wedbush100%4/45.8%top tier
UBS100%2/22.7%top tier
TD Cowen100%4/48.3%top tier
Stifel100%4/47%top tier
B of A Securities80%4/57.7%top tier
Oppenheimer80%4/57.3%top tier
Citigroup75%3/47.4%top tier
Evercore ISI Group67%2/3-0.7%top tier
Morgan Stanley67%2/36.1%top tier

BMO Capital has a 53% accuracy rate on 1,841 calls with a 2.3% average return, placing it in the middle of the pack. Top-tier firms covering ASND include RBC Capital (100% on 3 calls, 5.2% avg return), Wedbush (100% on 4, 5.8%), TD Cowen (100% on 4, 8.3%), and Stifel (100% on 4, 7.0%). Bottom-tier: Goldman Sachs (33% on 3, -0.2%) and Wells Fargo (50% on 4, 1.3%). BMO's initiation is not from a top-tier firm but is still credible.

Earnings Estimates

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0q$0.95$0.68 to $1.09$365.8M↑0 ↓0
0y$11.34$3.61 to $15.60$1.4B↑1 ↓0
+1y$8.16$6.64 to $8.78$2.0B↑1 ↓0
+1q$1.18$0.67 to $1.51$415.1M↑0 ↓0

Cross-Platform Signals

Insider Trades (90d)
5 buys / 0 sells
Institutional
NATIONAL BANK OF CANADA /FI/: exit (-100%)
Institutional
DEUTSCHE BANK AG\: exit (-100%)
Institutional
BlackRock, Inc.: exit (-100%)
Short Interest
Short: 357,768 | Exempt: 12 | TRF Vol: 520,177 | Short Ratio: 68.8% | Off-exchange volume (dark pool + OTC)

Insider trades are strongly bullish: CEO Jean Jacques Bienaime bought $492,654 worth on August 14, and other insiders (Scott Thomas Smith, Bienaime) made buys in May/June totaling ~$88,710. No insider sales reported. Institutional activity is mixed: State Street doubled its position (+488.5% to $137M), but BlackRock, Deutsche Bank, National Bank of Canada, and TD Asset Management all exited. Short interest is high at 68.8% of float, suggesting significant bearish positioning. The insider buying aligns with the bullish analyst signal, while the short interest creates potential for a squeeze if positive news hits.

Investment Themes

Documents Analyzed

Report based on filing metadata.

Track record

41 reports on ASND

Performance horizon

13 of 18 bullish or bearish reports moved the stock their way by T+60. Best: +26.62% at T+20 after the Jun 2, 2026 report. 23 of 26 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $271.96 Now $271.73 −0.08% settles Feb 12
  2. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $267.07 Now $271.73 +1.74% settles Feb 11
  3. Nov 12, 20264d ago 6-K Bullish 6/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
  4. Nov 12, 20264d ago Press Release Neutral 5/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
  5. Nov 6, 20269d ago 6-K Bullish 6/10 Entry $259.85 Now $271.73 +4.57% settles Feb 5
  6. Nov 6, 202610d ago Press Release Bullish 6/10 Entry $256.82 Now $271.73 +5.81% settles Feb 4
  7. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $253.45 Now $271.73 +7.21% settles Feb 3
  8. Nov 2, 202613d ago Institutional Cluster Bullish 4/10 Entry $250.17 Now $271.73 +8.62% settles Feb 1
  9. Oct 26, 202621d ago 6-K Bullish 5/10 Entry $245.85 Now $271.73 +10.53% settles Jan 25
  10. Oct 16, 20264w ago 6-K Bullish 7/10 Entry $225.25 Now $271.73 +20.63% settles Jan 13
Showing 10 of 41

US Market Status

Market Closed · Opens Tue (17h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 19, 2026